Published on: 12/3/16
A specialist cannabis-based medicine company has announced the development of two new medicines in the form of transdermal patches to relieve pain in Fibromyalgia and diabetic patients with nerve pain.
Patches deliver relief through CBD for Fibromyalgia and nerve pain in specific localized dosages
The National Pain Report covered the announcement of Cannabis Science on the two new products they have developed for pain management in Fibromyalgia and diabetic patients.
The new pharmaceutical medications deliver a specific dose of medication through the skin, and into the bloodstream, in the form of a transdermal patch that is a medicated adhesive placed on the skin.
The patch brings relief, and promotes healing to an injured area of the body. The benefit in comparison with other types of medication delivery for instance, oral, topical or intramuscular, is that the patches provide a controlled release. The high potency cannabinoid (CBD) extract slowly enters the bloodstream through the body’s heat melting a thin layer of medication embedded in an adhesive or through a porous membrane covering a reservoir of medication. CBD has anti-inflammatory and pain-relieving properties. The cannabidiol penetrates the central nervous system to deliver relief of pain.
A selection of our products
CEO of Cannabis Science, Raymond C. Dabney says these two new pharmaceutical applications are just the tip of the iceberg of what the company envisages for the future. Cannabis Science is looking at increasing its land capacity for growing and facilitating the production of its own products. It would like to be able to supply its scientists with raw materials to make formulations from. He says the company is also researching more potential needs for medical cannabis applications, and is developing methods to deliver different medications.
Dabney concludes by saying in the next few years, the demand for pharmaceutical formulations and applications will be expanding rapidly as more states nationwide legalize medical cannabis and cannabis derived medications.
It is estimated that Fibromyalgia affects 2 – 8% of the population with twice as many females than males. These people are in constant pain.
Peripheral Neuropathy (PN) is described as a disease affecting nerves, which may impair movement, sensation, or gland and organ functions. It may also impair other aspects of health, depending on the type of nerves affected.
The comments left by readers of the article were mostly from Fibromyalgia patients crying out for the product, or asking to be included in trials of the product. A level of desperation is apparent from the comments. Hopefully these patches will be available to patients soon, but as most say, if products are not on trial, or near being listed with the FDA for approval, getting them will be difficult, or even impossible.
CBD for Fibromyalgia
Some of the Fibromyalgia patients comment on CBD for Fibromyalgia as a successful treatment saying “CBD is proving to be one of the only substances so far that is improving autoimmune conditions like fibromyalgia and psoriasis.”
These people live with real pain on a daily basis, and most of them just want to be able to have a normal life, go to work and earn an in income.
Don’t suffer alone or in silence
If you suffer chronic pain and don’t live in a state where medical marijuana is legal, you can still get CBD medication via the Internet, as it is not an illegal substance in itself. Some people recommend a combination of THC and CBD for pain, and then it is a different kettle of fish. What everyone seems to agree on is that CBD for Fibromyalgia really helps. We’ll hope these skin patches receive mainstream recognition soon! Meanwhile, CBD gum also has a slow-release effect.
Disclaimer: Views expressed here do not necessarily reflect those of Endoca and its staff. This article is not intended to provide medical advice, diagnosis, treatment or cure. Endoca CBD products have not been approved by the US Food and Drug Administration (FDA).